Skip to Content
Merck
All Photos(4)

Documents

M2004

Sigma-Aldrich

N-Methyl-D-glucamine

99.0-100.5% (titration)

Synonym(s):

1-Deoxy-1-(methylamino)-D-glucitol, Meglumine

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C7H17NO5
CAS Number:
Molecular Weight:
195.21
Beilstein:
385906
EC Number:
MDL number:
UNSPSC Code:
12352104
PubChem Substance ID:
NACRES:
NA.22

Assay

99.0-100.5% (titration)

form

powder

autoignition temp.

~662 °F

mp

129-131.5 °C (lit.)

SMILES string

CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

InChI

1S/C7H17NO5/c1-8-2-4(10)6(12)7(13)5(11)3-9/h4-13H,2-3H2,1H3/t4-,5+,6+,7+/m0/s1

InChI key

MBBZMMPHUWSWHV-BDVNFPICSA-N

Looking for similar products? Visit Product Comparison Guide

General description

N-Methyl-D-glucamine, also known as methylglucamine, is an organic compound that belongs to the class of amino sugars. It is commonly used in pharmaceutical and biochemical applications as a resolving and buffering agent. Salts of N-methyl-D-glucamine have also been used for X-ray contrast media and nuclear imaging agents.

Application

N-Methyl-D-glucamine (NMG) can be used as a reactant to prepare water-soluble polymer for the selective removal of arsenic from aqueous water. It is also used in the development of various resins and gels containing NMG to remove different oxyanions.

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Andrea Barison et al.
Journal of cardiovascular medicine (Hagerstown, Md.), 16(10), 681-687 (2015-06-20)
In nonischaemic dilated cardiomyopathy (NICM), replacement myocardial fibrosis as detected by late gadolinium enhancement (LGE) at cardiovascular magnetic resonance (CMR) is associated with poor prognosis. We investigated the as-yet unexplored prognostic significance of interstitial fibrosis in NICM, using T1-mapping CMR.
Alexander Radbruch et al.
Radiology, 275(3), 783-791 (2015-04-08)
To compare changes in signal intensity (SI) ratios of the dentate nucleus (DN) and the globus pallidus (GP) to those of other structures on unenhanced T1-weighted magnetic resonance (MR) images between linear and macrocyclic gadolinium-based contrast agents (GBCAs). The study
Ntobeko A B Ntusi et al.
JACC. Cardiovascular imaging, 8(5), 526-536 (2015-04-22)
The goal of this study was to assess the diffuse myocardial fibrosis and edema in rheumatoid arthritis (RA) using multiparametric cardiac magnetic resonance (CMR) and the association of myocardial T1 and extracellular volume (ECV) with disease activity, duration, and cardiac
Raphaëlle Renard-Penna et al.
Radiology, 275(2), 458-468 (2015-01-20)
To compare the diagnostic performance of the magnetic resonance (MR) imaging-based Prostate Imaging Reporting and Data System (PI-RADS) and a Likert scale in the detection of prostate cancer in a cohort of patients undergoing initial prostate biopsy. This institutional review
Philipp Kickingereder et al.
Neuro-oncology, 17(8), 1139-1147 (2015-03-11)
To analyze the relevance of dynamic susceptibility-weighted contrast-enhanced MRI (DSC-MRI) derived relative cerebral blood volume (rCBV) analysis for predicting response to bevacizumab (BEV) in patients with recurrent glioblastoma (rGB). A total of 127 patients diagnosed with rGB receiving either bevacizumab

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service